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Levels of satisfaction rated by patients on a VAS appear in the table.
Main expectations expressed by patients were (by order of citations):
achieve pain relief (87%), slow knee OA progression (76%), reduce
physical handicap (61%), receive information on OA and its management
(16%), management of side-effects of therapies (12%), more prescrip-
tions of physiotherapy (7%).
Table 1: Levels of satisfaction rated by patients on the management of their knee OA
Outcome VAS score (mm):
m±sd
Overall level of satisfaction 69.3±23.7
Attention paid by the doctor to pain 73.0±22.3
Information on the disease and its management 71.4±22.5
Attention paid on physical handicap 69.4±23.6
Advice for daily activities 65.6±25.0
Surgery, if applicable 65.1±34.1
On pharmacological treatments efﬁcacy on pain and mobility 59.1±25.3
Physiotherapy 50.0±28.9
Conclusions: Overall, patient’s satisfaction on the management of their
knee OA was good. Attention paid to pain, functional impairment and
the requirement of information on the disease by French RH are highly
rated by patients. The lowest patient’s satisfaction scores regard efﬁcacy
of drugs and physiotherapy prescriptions.
This study has partly been supported by a grant from Genevrier Labora-
tories, Soﬁa Antipolis, France.
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Purpose: A number of differences have been noted in the past regarding
the risk for hip or knee osteoarthritis (OA). In addition, differences in both
the incidence, type and severity of disease have been noted between
men and women. In this study we investigated the role of variants in
eight genes which have been previously implicated in risk of knee OA but
not yet tested for genetic association with hip OA.
Methods: 260 men with clinical hip OA (American College of Rheumatol-
ogy criteria) and 292 age matched controls and 520 women with hip OA
and 380 age matched controls were collected in the Midlands region of
the UK. DNA samples from these individuals were genotyped at variants
in the AACT, ADAM12, CILP, COX-2, CD36, OPG, COMP and TNA genes
all of which had been previously implicated in risk of knee OA (Arthritis &
Rheumatism 2006; 54 (2): 533–539).
Results: Variants in the genes for AACT (rs4934 OR for minor al-
lele = 0.91 95%CI = 0.84−0.99), CD36 (rs1049654 OR=1.11 95%CI =
1.01−1.21) and TNA (rs13963, recessive OR=1.49 95%CI = 1.02−2.18)
were modestly associated with hip OA in women and a variant in the
CILP gene (rs2073711) was associated with hip OA in men (OR=1.23
95%CI = 1.01−1.49). A haplotype in the OPG gene (rs1564858–
rs2073618) was associated only in women (OR 1.29 95%CI = 1.06−1.56)
and a haplotype in the ADAM12 gene (rs1871054–rs3740199) was asso-
ciated only in men (OR=1.18 95%CI = 1.01−1.36). When both genders
were combined variants in the AACT (OR=0.89 95%CI 0.81−0.99), and
CD36 genes (OR=1.11 95%CI = 1.0−1.23) were signiﬁcantly associated
with risk of hip OA. With the exception of CD36 the effect sizes were all
smaller than those previously observed for knee OA.
Conclusions: Our data indicate that although there may be differences in
the genetic factors contributing to knee and hip OA there is some overlap
in gene effects at least in populations from the UK. Moreover, these data
suggest that genetic susceptibility to hip OA might affect men and women
differently.
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Purpose: Genetic risk factors are involved in knee osteoarthritis (OA), but
how genetic risk factors modify the knee joint and lead to its vulnerability
is not yet clear. Tibiofemoral malalignment is a biomechanical risk factor
involved in knee OA progression and development, but it is unclear how
tibiofemoral malalignment develops. Whether tibiofemoral malalignment
is under genetic control is the aim of the present study, wherein the
heritability of tibiofemoral alignment in sibling pairs will be investigated.
Methods: Patients from the GARP (Genetics, ARtrosis and Progression)
study, a prospective cohort study comprising sibling pairs with familial
OA at multiple joint sites, were utilized. Clinical characteristics of patients
were recorded by using standardized questionnaires. Radiographic sever-
ity of knee OA was assessed according to the Kellgren-Lawrence (KL)
method: radiographic knee OA was deﬁned as a KL score of at least 2.
Tibiofemoral anatomical angle was measured on digitized semi-ﬂexed
knee radiographs for both knees on a continuous scale. The heritability
of the tibiofemoral angle was estimated by comparing twice the sibling
variance divided by the total variance and were presented with 95%
conﬁdence intervals (95%CI). Heritability estimates were adjusted for
age, sex, body mass index, KL score and history of meniscectomy or
lower limb fracture.
Results: Three hundred sixty subjects (mean age 60 years, 81% women)
representing 180 families were studied. The mean (sd) tibiofemoral an-
gle of the right and left knees in the probands was 182.7º (2.9) and
182.8 (2.8) respectively, and in the siblings was not statistically different.
Radiographic knee OA was evident in 28.5% and 25.1% of probands
and siblings respectively. The unadjusted heritability estimates for the
tibiofemoral angle of the right and left knee were 0.48 and 0.38 respec-
tively. After adjustments estimates increased to 0.48 (95%CI 0.18−0.78)
and 0.50 (95%CI 0.21−0.79) for the right and left knee respectively.
Stratiﬁed analyses in sibling pairs with non-osteoarthritic right knees (93
sibling pairs) and left knees (109 sibling pairs) were done, revealing
adjusted heritability estimates for the tibiofemoral angle of the right and
left knees of 0.42 (95%CI 0.02−0.82) and 0.56 (95%CI 0.19−0.92).
Conclusions: High heritabilities were estimated for the tibiofemoral angle
in right and left knees, suggesting a substantial genetic component, which
was independent of clinical characteristics, radiographic knee OA or
previous injury. Tibiofemoral (mal)alignment could attribute to the genetic
predisposition for knee OA. The results of the present study need to be
conﬁrmed in other study populations.
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Purpose: Investigating the associations between plasma levels of a range
of cytokines and chemokines, Selenoprotein S (SELS) gene variation and
osteoarthritis (OA) subtypes.
Methods: The GARP study consists of 191 sibling pairs with symptomatic
OA at multiple joint sites. Previously, genetic variation at the C-reactive
protein (CRP) gene was shown to associate to serum high sensitive CRP
and hand OA in the GARP study. Recent studies showed association of
a single nucleotide polymorphism (SNP) in the SELS gene and plasma
inﬂammatory markers and CRP levels in patients with active Crohn’s
Disease and ﬁnally. To asses the relation between SELS gene variation,
inﬂammatory markers and OA subtypes in the GARP study, we have
measured plasma levels of 17 cytokines and chemokines and genetic
variation at the SELS gene.
Results: 9 out of 17 serum markers had 60% or more of the signals
above the detection limit of the method used and could be assessed
quantitatively (QN), whereas the remaining 8 markers were assessed
qualitatively (QL) using a measure of detectable versus not detectable.
The assessed levels of the QN analyzed cytokines and chemokines
and CRP levels showed substantial correlations, in order to reduce
redundancy between these markers we performed a principal component
analysis (PCA). This analysis revealed that 3 components underlie 61%
of the total plasma variation. The ﬁrst component explaining 34% of the
